Article Details

Seagen to Highlight Data from Novel Targeted Therapies at AACR

Retrieved on: 2021-04-09 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

Seagen to Highlight Data from Novel Targeted Therapies at AACR. View article details on hiswai:

Excerpt

... as well as its proprietary sugar-engineered antibody (SEA) technology. ... assessed and compared to TIGIT monoclonal antibodies (mAbs) with inert, ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up